Ebitda Cambio Fecha
AbbVie USD 6.91B 3.22B 2026-06
Acadia Pharmaceuticals USD 40.99M 42.62M 2026-06
ALKERMES USD 120.06M 19.15M 2026-09
Amgen USD 5.8B 1.25B 2026-09
Biogen USD 450.8M 198.9M 2026-06
BioMarin Pharmaceutical USD 54.32M 167.99M 2026-09
Bristol-Myers Squibb USD 3.48B 1.6B 2026-09
Coherus Biosciences USD -43.33M 4.7M 2025-09
Eli Lilly USD 9.46B 3.54B 2026-09
Gilead Sciences USD -9.31B 12.82B 2026-06
Heron Therapeutics USD -3.88M 5.63M 2024-09
Ionis Pharmaceuticals USD -95.22M 9.99M 2026-09
J&J USD 8.99B 721M 2026-06
Malin Corporation EUR -1.1M 200K 2024-12
Merck USD 1.42B 2.97B 2026-06
Minerva Neurosciences USD -4.36M 1.71M 2024-09
Nektar Therapeutics USD -38.9M 7.09M 2026-03
Neurocrine Biosciences USD 375.3M 185.4M 2026-09
Otsuka Holdings JPY 174.82B 14.19B 2026-09
Pfizer USD 6.36B 350M 2026-09
Regeneron Pharmaceuticals USD 1.66B 695.2M 2026-06
Vertex Pharmaceuticals USD 888.6M 436.6M 2026-09